Position in APGE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,981
+$2,887 QoQ
Shares Held
30
+130.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#265
of 285 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIGNATUREFD, LLC holds $13,806,120 across 160 Biotechnology names. APGE ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,593 | $2,778,210 | |
| 2 | ARGX |
Argenx SE
|
2,075 | $1,925,122 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,756 | $1,094,936 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,063 | $621,024 | |
| 5 | INCY |
Incyte Corp
|
4,178 | $473,618 | |
| 6 | GMAB |
Genmab A/S
|
16,442 | $451,661 | |
| 7 | EXEL |
Exelixis, Inc.
|
7,184 | $390,881 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
6,510 | $378,426 |
All Filings in APGE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,981 | 30 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,094 | 13 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $981 | 13 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $516 | 13 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,216 | 28 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $934 | 25 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||